Literature DB >> 12725532

Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases.

Michael S Serfas1, Angela L Tyner.   

Abstract

The tyrosine kinases Brk/PTK6/Sik, Srm, Frk/Rak/Gtk/Iyk/Bsk, and Src42A/Dsrc41 have a low degree of sequence homology to other known kinases, including one another. We show here that the exon structure of these kinases, which we will call the Brk family, is highly conserved and distinct from each of the major families of intracellular kinases containing SH3, SH2, and tyrosine kinase domains, including c-Src and Fyn. Brk/Sik and Srm are 1.1 kb apart on human chromosome 20q13.3 and likely are the result of duplication in cis. Several Brk family kinases have an inhibitory effect on Ras pathway signaling from receptor tyrosine kinases. Members of this family can act either in the membrane or at the nucleus, and may change localization patterns depending on external stimuli. Brk has been shown to phosphorylate two proteins in vivo: Sam68. a substrate for Src in mitosis that can substitute for Rev in nuclear export of RNAs; and BKS, a novel adaptor molecule. Brk also functions as a rapid downstream signaling intermediate following calcium-induced differentiation in keratinocytes. It is possible that Brk family kinases may share common functions and interaction partners, which remain for the most part unexamined.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725532     DOI: 10.3727/096504003108748438

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  53 in total

Review 1.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

2.  Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.

Authors:  Tiffany Tsui; W Todd Miller
Journal:  Biochemistry       Date:  2015-05-13       Impact factor: 3.162

3.  Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.

Authors:  Jessica Gierut; Yu Zheng; Wenjun Bie; Robert E Carroll; Susan Ball-Kell; Andrea Haegebarth; Angela L Tyner
Journal:  Gastroenterology       Date:  2011-07-08       Impact factor: 22.682

4.  Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine.

Authors:  Andrea Haegebarth; Wenjun Bie; Ruyan Yang; Susan E Crawford; Valeri Vasioukhin; Elaine Fuchs; Angela L Tyner
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

5.  Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition.

Authors:  Midan Ai; Ke Liang; Yang Lu; Songbo Qiu; Zhen Fan
Journal:  Cancer Biol Ther       Date:  2013-01-04       Impact factor: 4.742

6.  Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.

Authors:  Monika Kasprzycka; Miroslaw Majewski; Zhi-Jong Wang; Andrzej Ptasznik; Maria Wysocka; Qian Zhang; Michal Marzec; Phyllis Gimotty; Mark R Crompton; Mariusz A Wasik
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

Review 7.  Targeting protein tyrosine kinase 6 in cancer.

Authors:  Milica B Gilic; Angela L Tyner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-09-18       Impact factor: 10.680

8.  PTK6 regulates IGF-1-induced anchorage-independent survival.

Authors:  Hanna Y Irie; Yashaswi Shrestha; Laura M Selfors; Fabianne Frye; Naoko Iida; Zhigang Wang; Lihua Zou; Jun Yao; Yiling Lu; Charles B Epstein; Sridaran Natesan; Andrea L Richardson; Kornelia Polyak; Gordon B Mills; William C Hahn; Joan S Brugge
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

9.  Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.

Authors:  Nancy E Castro; Carol A Lange
Journal:  Breast Cancer Res       Date:  2010-08-05       Impact factor: 6.466

10.  The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.

Authors:  Patrick M Brauer; Yu Zheng; Mark D Evans; Carmen Dominguez-Brauer; Donna M Peehl; Angela L Tyner
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.